日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comparing of Efficacy and Safety Between Sintilimab Plus IBI305 and PD-1 Inhibitor Plus TKIs in Combination of TACE for uHCC

比较信迪利单抗联合IBI305与PD-1抑制剂联合TKIs在TACE治疗uHCC中的疗效和安全性

Ya, Houxiang; Wang, Kai; Qin, Huixia; Zhou, Yi; Lin, Hesheng; Liu, Chengyuan; Jiang, Kaiwen; Gu, Jing; Li, Shuqun

The Predictive Power of the Cystatin C-Creatinine Score in Assessing Frailty

胱抑素C-肌酐评分在评估衰弱中的预测能力

Deng, Li; Zheng, Xin; Chen, Yue; Liu, Chenan; Shi, Jinyu; Bu, Zhaoting; Liu, Xiaoyue; Zhao, Hong; Li, Shuqun; Yin, Bing; Xing, Siyu; Shi, Hanping

The PLANES model for unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus lenvatinib and PD-1 inhibitors: a multicenter, retrospective study

PLANES模型用于评估经导管动脉化疗栓塞联合乐伐替尼和PD-1抑制剂治疗不可切除肝细胞癌的效果:一项多中心回顾性研究

Ya, Houxiang; Wang, Kai; Wu, Jiayi; Wu, Junyi; Zeng, Zhenxin; Li, Yinan; Ou, Xiangye; Song, Huachun; Yan, Maolin; Li, Shuqun

Whether Adjuvant TACE Plus TKI Therapy is More Effective Than TACE Alone in HCC Patients at High Risks of Recurrence Following Radical Hepatectomy

辅助性TACE联合TKI疗法是否比单纯TACE疗法更适用于根治性肝切除术后复发风险高的肝细胞癌患者

Li, Yaohua; Wang, Kai; Qin, Huixia; Huo, Shengjun; Jiang, Kaiwen; Xia, Jing; Gu, Jing; Ya, Houxiang; Suo, Liya; Wang, Dejie; Huang, Xiaowang; Li, Shuqun

Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Sintilimab Plus Bevacizumab Biosimilar in the Treatment of Unresectable Hepatocellular Carcinoma

经动脉化疗栓塞联合信迪利单抗加贝伐单抗生物类似药治疗不可切除肝细胞癌的疗效和安全性分析

Qin, Huixia; Jiang, Kaiwen; Liu, Chengyuan; Lin, Hesheng; Xia, Jing; Ya, Houxiang; Gu, Jing; Suo, Liya; Li, Bo; Deng, Xin; Wang, Dejie; Huang, Xiaowang; Li, Shuqun

NCR as a biomarker for nutritional status and inflammation in predicting outcomes in patients with cancer cachexia: a prospective, multicenter study

NCR作为营养状况和炎症的生物标志物在预测癌症恶病质患者预后中的作用:一项前瞻性多中心研究

Li, Xiangrui; Deng, Li; Xie, Hailun; Li, Shuqun; Zhao, Hong; Liu, Tong; Liu, Xiaoyue; Lin, Shiqi; Liu, ChengAn; Shi, Han-Ping

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway.

RBP7 敲低抑制人类肝细胞癌的增殖并激活 p38 MAPK 通路

Li Jinhai, Zhai Huawei, Cai Fujing, Zhang Xian, Zhou Yu, Li Shuqun, Song Huachun, Zhang Haifeng, Sun Guangzheng, Zhu Minghui, Yuan Jing, Zhang Ningxin, Yan Maolin

Case report: Complete response after transcatheter arterial chemoembolization combined with donafenib plus tislelizumab therapy for hepatocellular carcinoma with main trunk portal vein tumor thrombus in a patient coinfected with HIV and HBV

病例报告:一名合并HIV和HBV感染的肝细胞癌患者,在接受经导管动脉化疗栓塞联合多纳非尼和替雷利珠单抗治疗后,肿瘤完全缓解。

Xiao, Xuhua; Fu, Haixiao; Qin, Huixia; Xu, Longkuan; Gu, Jing; Zhang, Zhan; Ya, Houxiang; Jiang, Kaiwen; Jian, Zhiyuan; Li, Shuqun

Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study

乐伐替尼联合抗PD-1抗体及经导管动脉化疗栓塞治疗伴门静脉癌栓的肝细胞癌的疗效:一项回顾性多中心研究

Ou, Xiangye; Wu, Junyi; Wu, Jiayi; Fu, Yangkai; Zeng, Zhenxin; Li, Shuqun; Li, Yinan; Liu, Deyi; Li, Han; Li, Bin; Zhou, Jianyin; Zhuang, Shaowu; Cheng, Shuqun; Zhang, Zhibo; Wang, Kai; Qu, Shuang; Yan, Maolin

The quality of life impacting factors in malnourished patients with gastric cancer

影响营养不良胃癌患者生活质量的因素

Zhao, Hong; Liu, Chenan; Ruan, Guotian; Zheng, Xin; Chen, Yue; Lin, Shiqi; Liu, Xiaoyue; Shi, Jinyu; Li, Xiangrui; Li, Shuqun; Shi, Hanping